Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples